Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2015

View Archived Issues

Astellas Pharma presents milestones of fourth quarter of fiscal 2014

Sun Biomedical agrees to acquire Dimerix Bioscience

Eisai patents FGFR-4 inhibitors

Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function

Tonix Pharmaceuticals starts phase III trial of TNX-102 SL for fibromyalgia

Dicerna expands phase I trial of DCR-MYC to include PNET cohort

Discovery Labs' phase IIa study of Aerosurf meets key objectives

Luye Pharma completes three studies for risperidone extended-release microspheres

FDA grants fast track designation to TRC-105 for renal cell carcinoma

Xadago launched in Germany for mid- to late-stage Parkinson's disease

ISIS-664844 selectively targets the P23H variant of Rhodopsin

Vaccination with FSPs shows potential for the treatment of MSI-H CRC

FDA approves Treximet for use in pediatric migraine

Novartis reports development of complement factor B inhibitors

FORUM Pharmaceuticals patents nAChR alpha7 agonists

Chugai discloses DDR1 inhibitors

Taisho develops antibacterial hydroxamic acids

Boehringer Ingelheim exercises option for Pharmaxis drug candidate

Preliminary phase I trial results presented on DC vaccination therapy for AML

Selecta and Genethon to investigate technology enabling repeat dosing of gene therapies

Alnylam files for permission to start phase I/II trial of alpha1-antitrypsin RNAi therapeutic

Mitsubishi Tanabe files application in Japan for Remicade in Kawasaki disease

Sacituzumab govitecan awarded FDA fast track designation for NSCLC

Bristol-Myers Squibb's IPN-007 receives U.S. orphan status for progressive supranuclear palsy

Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...